Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 5
1969 6
1970 8
1971 5
1973 2
1974 1
1975 4
1976 9
1977 11
1978 9
1979 3
1980 16
1981 22
1982 34
1983 29
1984 37
1985 44
1986 21
1987 29
1988 39
1989 29
1990 41
1991 40
1992 22
1993 35
1994 38
1995 30
1996 48
1997 49
1998 36
1999 40
2000 42
2001 46
2002 40
2003 28
2004 23
2005 24
2006 15
2007 31
2008 28
2009 32
2010 38
2011 52
2012 47
2013 60
2014 48
2015 55
2016 51
2017 44
2018 25
2019 39
2020 34
2021 47
2022 53
2023 37
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,549 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.
Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, Akuta N, Yoneda M, Iwasa M, Yoneda M, Otsuka M, Tamaki N, Kogiso T, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Tokushige K, et al. Among authors: tamaki n. J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17. J Gastroenterol. 2021. PMID: 34533632 Free PMC article. Review.
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.
En Li Cho E, Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, Tan DJH, Lim WH, Yong JN, Zeng R, Chee D, Nah B, Lesmana CRA, Bwa AH, Win KM, Faulkner C, Aboona MB, Lim MC, Syn N, Kulkarni AV, Suzuki H, Takahashi H, Tamaki N, Wijarnpreecha K, Huang DQ, Muthiah M, Ng CH, Loomba R. En Li Cho E, et al. Among authors: tamaki n. Gut. 2023 Nov;72(11):2138-2148. doi: 10.1136/gutjnl-2023-330110. Epub 2023 Jul 25. Gut. 2023. PMID: 37491159
Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.
Maddahi J, Agostini D, Bateman TM, Bax JJ, Beanlands RSB, Berman DS, Dorbala S, Garcia EV, Feldman J, Heller GV, Knuuti JM, Martinez-Clark P, Pelletier-Galarneau M, Shepple B, Tamaki N, Tranquart F, Udelson JE. Maddahi J, et al. Among authors: tamaki n. J Am Coll Cardiol. 2023 Oct 17;82(16):1598-1610. doi: 10.1016/j.jacc.2023.08.016. J Am Coll Cardiol. 2023. PMID: 37821170 Clinical Trial.
Editorial: Atherosclerosis and functional imaging.
Huang JY, Lin YH, Hung CL, Chen WP, Tamaki N, Bax JJ, Morris DA, Korosoglou G, Wu YW. Huang JY, et al. Among authors: tamaki n. Front Cardiovasc Med. 2022 Dec 6;9:1053100. doi: 10.3389/fcvm.2022.1053100. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36561766 Free PMC article. No abstract available.
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies.
Chan KE, Ong EYH, Chung CH, Ong CEY, Koh B, Tan DJH, Lim WH, Yong JN, Xiao J, Wong ZY, Syn N, Kaewdech A, Teng M, Wang JW, Chew N, Young DY, Know A, Siddiqui MS, Huang DQ, Tamaki N, Wong VW, Mantzoros CS, Sanyal A, Noureddin M, Ng CH, Muthiah M. Chan KE, et al. Among authors: tamaki n. Clin Gastroenterol Hepatol. 2024 Mar;22(3):488-498.e14. doi: 10.1016/j.cgh.2023.09.018. Epub 2023 Sep 28. Clin Gastroenterol Hepatol. 2024. PMID: 37775028 Review.
Reply.
Tamaki N, Kurosaki M, Izumi N. Tamaki N, et al. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1419-1420. doi: 10.1016/j.cgh.2019.01.038. Epub 2019 Jan 30. Clin Gastroenterol Hepatol. 2019. PMID: 30710699 No abstract available.
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), versus placebo in patients with non-alcoholic fatty liver disease.
Nakajima A, Eguchi Y, Yoneda M, Imajo K, Tamaki N, Suganami H, Nojima T, Tanigawa R, Iizuka M, Iida Y, Loomba R. Nakajima A, et al. Among authors: tamaki n. Aliment Pharmacol Ther. 2021 Nov;54(10):1263-1277. doi: 10.1111/apt.16596. Epub 2021 Sep 16. Aliment Pharmacol Ther. 2021. PMID: 34528723 Free PMC article. Clinical Trial.
Clinical Perspectives of Theranostics.
Okamoto S, Shiga T, Tamaki N. Okamoto S, et al. Among authors: tamaki n. Molecules. 2021 Apr 13;26(8):2232. doi: 10.3390/molecules26082232. Molecules. 2021. PMID: 33924345 Free PMC article. Review.
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. Huang DQ, et al. Among authors: tamaki n. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):829-836. doi: 10.1016/S2468-1253(23)00157-7. Epub 2023 Jul 4. Lancet Gastroenterol Hepatol. 2023. PMID: 37419133 Free PMC article.
1,549 results